|
Delayed
Australian S.E.
11:11:58 18/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 0.1250 AUD | 0.00% |
|
+4.17% | -16.67% |
Company Valuation: Amplia Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2023 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 16.49 | 27.16 | 120.6 | 64.16 | - | - |
| Change | - | - | 343.99% | -46.78% | - | - |
| Enterprise Value (EV) 1 | 16.49 | 27.16 | 92.72 | 46.26 | 40.76 | 46.76 |
| Change | - | - | 241.42% | -50.1% | -11.89% | 14.72% |
| P/E | -2.64x | -3.27x | -14.3x | -5.43x | -17.9x | -11.4x |
| PBR | - | - | - | - | - | - |
| PEG | - | - | 0.6x | -0.1x | 0.3x | -0.2x |
| Capitalization / Revenue | - | - | - | - | 6.75x | 6.75x |
| EV / Revenue | - | - | - | - | 4.29x | 4.92x |
| EV / EBITDA | - | - | -11.2x | -4.02x | -10.2x | -7.79x |
| EV / EBIT | - | - | -11.1x | -3.99x | -9.94x | -7.67x |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.0322 | -0.0214 | -0.0164 | -0.023 | -0.007 | -0.011 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | 9.5 | 9.5 |
| EBITDA 1 | - | - | -8.297 | -11.5 | -4 | -6 |
| EBIT 1 | - | - | -8.389 | -11.6 | -4.1 | -6.1 |
| Net income 1 | -6.242 | -6.572 | -7.707 | -11.6 | -4.1 | -6.1 |
| Net Debt 1 | - | - | -27.85 | -17.9 | -23.4 | -17.4 |
| Reference price 2 | 0.0850 | 0.0700 | 0.2350 | 0.1250 | 0.1250 | 0.1250 |
| Nbr of stocks (in thousands) | 194,006 | 387,953 | 513,072 | 513,312 | - | - |
| Announcement Date | 30/5/23 | 30/5/25 | 29/5/26 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.22x | - | -3.8x | - | 43.94M | |
| 20.48x | 7.21x | 14.48x | 1.45% | 69.69B | |
| 31.56x | 9.12x | 44.38x | 0.04% | 61.24B | |
| -74.83x | 14.47x | -69.78x | -.--% | 26.77B | |
| -14.57x | 5.25x | -6.6x | -.--% | 24.07B | |
| 27.63x | 5.23x | 17.38x | -.--% | 20.39B | |
| 45.45x | 16.69x | 33.86x | 0.33% | 15.72B | |
| 17.54x | 5.22x | 12.19x | -.--% | 14.07B | |
| -14.86x | 3350.32x | -17.13x | -.--% | 13.8B | |
| -83.79x | 7.67x | -63.48x | -.--% | 12.22B | |
| Average | -5.06x | 380.13x | -3.85x | 0.2% | 25.8B | |
| Weighted average by Cap. | 5.05x | 187.42x | 6.76x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATX Stock
- Valuation Amplia Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
